AAAAAA
Results:
1-23
|
Results: 23
Authors:
Bakris, GL
Citation: Gl. Bakris, Treatment of stage I hypertension and development of renal dysfunction, J HUM HYPER, 15(2), 2001, pp. 81-84
Authors:
Bakris, GL
Citation: Gl. Bakris, Angiotensin-converting enzyme inhibition to enhance vascular health-clinical and research models, AM J HYPERT, 14(8), 2001, pp. 264S-269S
Authors:
Griffin, KA
Picken, M
Bakris, GL
Bidani, AK
Citation: Ka. Griffin et al., Comparative effects of selective T- and L-type calcium channel blockers inthe remnant kidney model, HYPERTENSIO, 37(5), 2001, pp. 1268-1272
Authors:
Agodoa, LY
Appel, L
Bakris, GL
Beck, G
Bourgoignie, J
Briggs, JP
Charleston, J
Cheek, D
Cleveland, W
Douglas, JG
Douglas, M
Dowie, D
Faulkner, M
Gabriel, A
Gassman, J
Greene, T
Hall, Y
Hebert, L
Hiremath, L
Jamerson, K
Johnson, CJ
Kopple, J
Kusek, J
Lash, J
Lea, J
Lewis, JB
Lipkowitz, M
Massry, S
Middleton, J
Miller, ER
Norris, K
O'Connor, D
Ojo, A
Phillips, RA
Pogue, V
Rahman, M
Randall, OS
Rostand, S
Schulman, G
Smith, W
Thornley-Brown, D
Tisher, CC
Toto, RD
Wright, JT
Xu, SC
Citation: Ly. Agodoa et al., Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial, J AM MED A, 285(21), 2001, pp. 2719-2728
Authors:
Bakris, GL
Citation: Gl. Bakris, A practical approach to achieving recommended blood pressure goals in diabetic patients, ARCH IN MED, 161(22), 2001, pp. 2661-2667
Authors:
Vora, JP
Ibrahim, HAA
Bakris, GL
Citation: Jp. Vora et al., Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management, J HUM HYPER, 14(10-11), 2000, pp. 667-685
Authors:
Koshy, S
Bakris, GL
Citation: S. Koshy et Gl. Bakris, Therapeutic approaches to achieve desired blood pressure goals: Focus on calcium channel blockers, CARDIO DRUG, 14(3), 2000, pp. 295-301
Authors:
Bakris, GL
Williams, M
Dworkin, L
Elliott, WJ
Epstein, M
Toto, R
Tuttle, K
Douglas, J
Hsueh, W
Sowers, J
Citation: Gl. Bakris et al., Preserving renal function in adults with hypertension and diabetes: A consensus approach, AM J KIDNEY, 36(3), 2000, pp. 646-661
Authors:
Keefe, DL
Bakris, GL
Citation: Dl. Keefe et Gl. Bakris, 20th-century advances in clinical pharmacology, J CLIN PHAR, 40(9), 2000, pp. 907-907
Authors:
Basta, E
Bakris, GL
Citation: E. Basta et Gl. Bakris, Evolution of drugs that preserve renal function, J CLIN PHAR, 40(9), 2000, pp. 978-989
Authors:
Bakris, GL
Whelton, P
Weir, M
Mimran, A
Keane, W
Schiffrin, E
Citation: Gl. Bakris et al., The future of clinical trials in chronic renal disease: Outcome of an NIH/FDA/physician specialist conference, J CLIN PHAR, 40(8), 2000, pp. 815-825
Authors:
Bakris, GL
Citation: Gl. Bakris, Hypertension and the progression of renal disease, DIALYSIS T, 29(4), 2000, pp. 187
Authors:
Bakris, GL
Siomos, M
Richardson, D
Janssen, I
Bolton, WK
Hebert, L
Agarwal, R
Catanzaro, D
Citation: Gl. Bakris et al., ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure, KIDNEY INT, 58(5), 2000, pp. 2084-2092
Authors:
Sowers, JR
Bakris, GL
Citation: Jr. Sowers et Gl. Bakris, Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus - Reply, N ENG J MED, 343(8), 2000, pp. 580-581
Authors:
Sowers, JR
Bakris, GL
Citation: Jr. Sowers et Gl. Bakris, Antihypertensive therapy and the risk of type 2 diabetes mellitus, N ENG J MED, 342(13), 2000, pp. 969-970
Authors:
Bakris, GL
Weir, MR
Citation: Gl. Bakris et Mr. Weir, Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern?, ARCH IN MED, 160(5), 2000, pp. 685-693
Authors:
Weir, MR
Maibach, EW
Bakris, GL
Blach, HR
Chawla, P
Messerli, FH
Neutel, JM
Weber, MA
Citation: Mr. Weir et al., Implications of a health lifestyle and medication analysis for improving hypertension control, ARCH IN MED, 160(4), 2000, pp. 481-490
Authors:
Sheinfeld, GR
Bakris, GL
Citation: Gr. Sheinfeld et Gl. Bakris, Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients, AM J HYPERT, 12(8), 1999, pp. 80S-85S
Authors:
Bakris, GL
Lass, NA
Glock, D
Citation: Gl. Bakris et al., Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors, KIDNEY INT, 56(1), 1999, pp. 206-210
Authors:
Griffin, KA
Picken, MM
Bakris, GL
Bidani, AK
Citation: Ka. Griffin et al., Class differences in the effects of calcium channel blockers in the rat remnant kidney model, KIDNEY INT, 55(5), 1999, pp. 1849-1860
Authors:
Bakris, GL
Citation: Gl. Bakris, When to discontinue ACE inhibitors for nephropathy, POSTGR MED, 106(1), 1999, pp. 29-29
Authors:
Bakris, GL
Citation: Gl. Bakris, Renin-angiotensin system in diabetic nephropathy: From bench to bedside - Introduction, MIN ELECT M, 24(6), 1998, pp. 361-361
Authors:
Rabelink, TJ
Bakris, GL
Citation: Tj. Rabelink et Gl. Bakris, The renin-angiotensin system in diabetic nephropathy: The endothelial connection, MIN ELECT M, 24(6), 1998, pp. 381-388
Risultati:
1-23
|